Refractory
When standard approaches lose their hold, understanding how the biology adapted.
When standard approaches lose their hold, the biology hasn't failed, it has adapted, and understanding how it adapted is where the next decision begins.
2 papers. Why they matter here.
- Paper 1
Tumour Ecology and Evolutionary Stability
Read the paper →Resistance as ecological adaptation, not biological inevitability. What ecological collapse looks like and what it permits.
- Paper 2
Cancer as an Ecological and Evolutionary System
Read the paper →Aktipis on cooperative breakdown. Gatenby on adaptive therapy. Zhang on clinical validation. The full evolutionary argument for why resistance emerged and what can be done about it.
8 papers. Why they matter here.
- Paper 1
Bipolar Androgen Therapy: Clinical Validation
Read the paper →The primary escalation modality. How BAT exploits the adaptive state that chronic deprivation produced. PSA50 response rates 77-94%. The oscillation principle applied to CRPC.
- Paper 2
Rapamycin, mTOR Oscillation, and the p53-MDM2 Axis
Read the paper →Maintaining quality-control capacity during and after escalation.
- Paper 3
Testosterone, p53, and the MDM2 System
Read the paper →The AR biology underlying both resistance and the BAT mechanism.
- Paper 4
MDM2 as Convergence Point
Read the paper →What the convergence point looks like when containment has failed, and what restoring the upstream metabolic environment still achieves.
- Paper 5
Signal, Stress, and Selection
Read the paper →How the four-signal architecture applies during escalation, and what returning to constraint management requires after BAT.
- Paper 6
From Intervention to Environment
Read the paper →The logic of returning to constraint management after state forcing. Why escalation is cyclic, not continuous.
- Paper 7
Chronic Activation vs Oscillation
Read the paper →Why restoring oscillation, rather than enforcing new suppression, is the mechanism of BAT and the logic of post-escalation management.
- Paper 8
A Hierarchy of Biological Signals
Read the paper →Phase 5 operates at Levels 4 and 5, phenotype expression and clinical outcome. The hierarchy explains why the monitoring tools change and what the framework is still accountable to.